<DOC>
	<DOCNO>NCT01208779</DOCNO>
	<brief_summary>This observational study estrogen receptor positive early breast cancer patient aim evaluate patient ' compliance aromatase inhibitor ( AI ) therapy collect country-specific data estrogen receptor positive early breast cancer patient include data demography , disease characteristic disease management .</brief_summary>
	<brief_title>Epidemiology Study Postmenopausal Women With Estrogen Receptor Positive Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Postmenopausal females estrogen receptor positive breast cancer currently treat aromatase inhibitor ( AI ) medication Provision subject inform consent If participate clinical trial , subject take part study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Compliance</keyword>
	<keyword>HR+ breast cancer</keyword>
	<keyword>epidemiology</keyword>
</DOC>